Verona Pharma plc (VRP.L) (VRP) News Today → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free VRP Stock Alerts GBX 55 +3.00 (+5.77%) (As of 10/29/2020) Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVerona Pharma plc (VRP.L) (LON:VRP) Share Price Passes Above Two Hundred Day Moving Average of $55.00americanbankingnews.com - April 27 at 3:42 AMVerona Pharma plc (VRNA)finance.yahoo.com - April 24 at 3:47 PMStrong Buy Recommendation on Verona Pharma Backed by Positive Phase III Results and Robust Commercial Strategymarkets.businessinsider.com - March 8 at 9:40 PMBuy Rating Affirmed on Verona Pharma Ahead of Ensifentrine’s Expected FDA Approval and Strong Financial Standingmarkets.businessinsider.com - March 4 at 3:10 PMMichael Austwick Joins Verona Pharma as Non-Executive Directormarkets.businessinsider.com - February 1 at 7:30 AMBTIG Keeps Their Buy Rating on Verona Pharma (VRNA)markets.businessinsider.com - January 3 at 10:33 AMVerona Pharma enters upto $400M debt facilitymsn.com - January 2 at 8:07 AMBTIG Reaffirms Their Buy Rating on Verona Pharma (VRNA)markets.businessinsider.com - January 1 at 8:38 AMBuy Rating for Verona Pharma: Strong Potential of Ensifentrine, Attractive Entry Point and Solid Financialsmarkets.businessinsider.com - November 3 at 8:31 AMPositive Outlook for Verona Pharma’s Stock Amid Anticipated FDA Approval and Promising Market Potential for Ensifentrinemarkets.businessinsider.com - October 25 at 2:56 PMVerona Pharma to Report Third Quarter 2023 Financial Results and Provide Corporate Updatebenzinga.com - October 19 at 8:26 AMVerona Pharma: De-Risked COPD Biotech Play, Approval Likely Coming Soonmsn.com - September 5 at 2:51 AMCanaccord Genuity Reiterates Verona Pharma Plc - ADR (VRNA) Buy Recommendationmsn.com - September 2 at 4:13 AMExpert Ratings for Verona Pharmabenzinga.com - September 1 at 6:12 PMChristina Ackermann Joins Verona Pharma as Non-Executive Directorbenzinga.com - August 31 at 3:45 AMH.C. Wainwright Keeps Their Buy Rating on Verona Pharma (VRNA)markets.businessinsider.com - August 4 at 5:27 PMVerona Pharma to Present at 43rd Annual Canaccord Growth Conferencebenzinga.com - July 26 at 4:22 PMVerona Pharma to Report Second Quarter 2023 Financial Results and Provide Corporate Updatebenzinga.com - July 20 at 7:32 AMTruist Securities Reiterates Verona Pharma Plc - ADR (VRNA) Buy Recommendationmsn.com - June 28 at 12:30 PMWedbush Reiterates Verona Pharma Plc - ADR (VRNA) Outperform Recommendationmsn.com - June 28 at 12:30 PMBTIG Sticks to Their Buy Rating for Verona Pharma (VRNA)markets.businessinsider.com - June 28 at 7:30 AMWedbush Reaffirms Their Buy Rating on Verona Pharma (VRNA)markets.businessinsider.com - May 25 at 9:22 AMVerona Pharma a buy at Jefferies on COPD nebulizermsn.com - May 22 at 12:53 PMAnalysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Verona Pharma (VRNA) and Arcus Biosciences (RCUS)markets.businessinsider.com - May 10 at 7:42 AMVerona Pharmafool.co.uk - February 11 at 3:37 PMHere's Why Momentum in Verona Pharma PLC American Depositary Share (VRNA) Should Keep goingmsn.com - November 15 at 1:54 PMVerona Pharma plc (VRNA) Q3 2022 Earnings Call Transcriptseekingalpha.com - November 9 at 6:29 PMVerona Pharma Announces Analyses Demonstrating Ensifentrine Reduced Exacerbation Rates Across Subgroups in Phase 3 ENHANCE-2 Trial for COPDbenzinga.com - October 14 at 2:13 AMBiotech Analysis Central Preview Series: Verona Pharmaseekingalpha.com - October 6 at 7:39 PMShort Volatility Alert: Verona Pharma plcmarkets.businessinsider.com - September 22 at 1:06 PMVerona Pharma to Present at H.C. Wainwright 24th Annual Global Investment Conferenceyahoo.com - August 29 at 3:50 AMVerona Pharma strengthens commercialization leadership teamfinance.yahoo.com - August 24 at 4:14 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Centessa Pharmaceuticals plcbenzinga.com - August 10 at 6:29 PMVerona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 9 at 5:13 AMVerona Pharma to Announce Top-line Data from Phase 3 ENHANCE-2 Trial of Nebulized Ensifentrine for COPDfinance.yahoo.com - August 8 at 7:13 PMSCA Pharma Names Louis Pace as Chief Financial Officer and Chief Information Officerbenzinga.com - July 15 at 1:39 PMHow Much Upside is Left in Verona Pharma PLC American Depositary Share (VRNA)? Wall Street Analysts Think 283%finance.yahoo.com - July 15 at 1:39 PMVerona Pharma Completes Enrollment in Phase 3 ENHANCE-1 Trial Evaluating Ensifentrine for Maintenance Treatment of COPDbenzinga.com - June 9 at 2:46 AMSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Centessa Pharmaceuticals plc - CNTAbenzinga.com - June 5 at 3:02 AMVerona Pharma to Present at Jefferies Healthcare Conferencefinance.yahoo.com - May 25 at 3:35 AM Get Verona Pharma plc (VRP.L) News Delivered to You Automatically Sign up to receive the latest news and ratings for VRP and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden to Launch “FedNOW” [Move Your Money Now] (Ad)Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar... Get your free information kit NOW, before it's too late. VRP Media Mentions By Week VRP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRP News Sentiment▼0.670.35▲Average Medical News Sentiment VRP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRP Articles This Week▼10▲VRP Articles Average Week Get Verona Pharma plc (VRP.L) News Delivered to You Automatically Sign up to receive the latest news and ratings for VRP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:VRP) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmith$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc (VRP.L) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
